(Q49582000)
Statements
1 reference
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML. (English)
1 reference
A Hochhaus
1 reference
C Schütz
1 reference
S Inselmann
1 reference
S Saussele
1 reference
C T Dietz
1 reference
M C Müller
1 reference
E Eigendorff
1 reference
C A Brendel
1 reference
S K Metzelder
1 reference
T H Brümmendorf
1 reference
C Waller
1 reference
J Dengler
1 reference
M E Goebeler
1 reference
R Herbst
1 reference
G Freunek
1 reference
S Hanzel
1 reference
T Illmer
1 reference
Y Wang
1 reference
T Lange
1 reference
F Finkernagel
1 reference
R Hehlmann
1 reference
M Huber
1 reference
A Neubauer
1 reference
J Guilhot
1 reference
F X Mahon
1 reference
M Pfirrmann
1 reference
A Burchert
1 reference
30 January 2018
1 reference
1 reference
Identifiers
1 reference